Used as a chiral building block in the synthesis of peptide-based pharmaceuticals and bioactive molecules. Its structure incorporates a fluorenylmethyloxycarbonyl (Fmoc) protecting group, making it especially valuable in solid-phase peptide synthesis (SPPS). The (R)-configuration at the 2-position provides stereochemical control, enabling the development of stereoselective compounds. Commonly employed in the preparation of protease inhibitors, receptor ligands, and other drug candidates where conformational restriction and defined stereochemistry are critical for biological activity.